Kenyan Study Could Help Other African Countries Improve Hiv Blood-transfusion Strategies (p 657)August 22, 2001A 1994 study which highlighted the problem of HIV-1 transmission from blood-transfusion programmes in Kenya-and resulted in positive government action-could help other African countries develop safer blood-transfusion strategies. Little support for blood-safety programmes has been provided to less-developed countries over the past decade. The Kenya Ministry of Health did a collaborative multicentre assessment with Robert Janssen and colleagues from the Centres for Disease Control, Atlanta, USA. The aims of this study were to establish the risk of HIV transmission by transfusion in Kenya, to promote awareness of blood safety issues in a country with a mature HIV epidemic, and to identify methods to reduce the risk of HIV transmission by blood transfusion. The investigators collected information and blood samples from all blood donors and pretransfusion samples from all recipients in six government hospitals in Kenya. Blood donations were screened for HIV according to standard practice in the hospital laboratories. Test results at a reference laboratory at the US Centres for Disease Control were compared with those of the hospital laboratories and risk of transfusion-associated HIV transmission was calculated. The prevalence of HIV among blood donors was 6.4% and varied by hospital (range 2%-20%). HIV-test results were available for 1290 donor-recipient pairs. Of these, 26 HIV-positive donations were given to HIV-negative patients. The investigators estimated that 2% of transfusions transmitted HIV. Problems in the hospitals that contributed to transfusion risk included inconsistent refrigeration, data-entry errors, equipment failure, and lack of a quality-assurance programme. Robert Janssen comments: "This rapid assessment provided important information for the development and implementation of programmes aimed at improving blood safety. Based on these results, the Kenya Ministry of Health identified support for the purchase and distribution of rapid HIV test kits and developed a national training programme to improve laboratory practices. Universal screening of all blood donations was emphasised at all hospitals. With an accurate assessment completed, and a national response planned, international aid funding was secured to implement training programmes, to improve recruitment of volunteer donors, to develop regional transfusion centres, and to develop a standardised quality-assurance programme. In these ways, this assessment helped to specify the areas that needed improvement and mobilise the resources and political commitment needed to address them. This rapid assessment may serve as an example other countries could use to assess the safety of their blood supply and to identify procedures to improve blood safety." Lancet |
|||||||||||||||||||||
| Related HIV Current Events and HIV News Articles Many pregnant women avoid HIV screening in Africa 'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. An atomic-level look at an HIV accomplice Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. No-entry zones for AIDS virus The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. Hoping for a fluorescent basket case Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Indiana U. at APHA: Studies about why men and women use lubricants during sex An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex. More HIV Current Events and HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||